Research Figures
Data from the Scientific Report 2022
- 489 Projects
- 355 Clinical Trials
- 802 Publications
- 6332 Total Impact Factor
News
The amino acid L-serine shows efficacy in treating patients with mutations in GRIN genes
A clinical trial led by Dr Àngels García-Cazorla (IRSJD), has demonstrated the potential of the amino acid L-serine, administered as an oral supplement, to improve the function of glutamate receptors in patients with GRINpathies. The trial involved 24 children from different hospitals in Spain.
Researchers from IRSJD and IRB Barcelona unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues
A team from Institut de Recerca Sant Joan de Déu and IRB Barcelona has studied the cases of four children who have experienced two cancers during childhood and has addressed the origin of the second tumour. The work has been published in the journal Cancer Discovery.
Interviews
César Galo Garcia Fontecha
Head of the Orthopaedic Surgery and Traumatology Group
“Learning about what others are doing allows us to improve and develop new ideas in order to advance in the world of research.”
Read more More Interviews
Agenda
IV Jornada Científica del IRSJD
During the Conference, intramural and external collaboration projects will be presented, as well as the three Catalan innovation networks led by members of the Institute and some of the thesis being developed within the framework of the IRSJD.